Expression of protein kinase C β1 confers resistance to TNFα‐ and paclitaxel‐induced apoptosis in HT‐29 colon carcinoma cells
暂无分享,去创建一个
C. Isidoro | M. Démoz | P. Cesaro | R. Castino | G. Bonelli | F. Baccino | E. Raiteri
[1] W. Karnes,et al. Distinct protein kinase C isozymes signal mitogenesis and apoptosis in human colon cancer cells. , 1999, Gastroenterology.
[2] A. Larsen,et al. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Westwick,et al. Cytokine-induced Apoptosis in Epithelial HT-29 Cells Is Independent of Nitric Oxide Formation , 1999, The Journal of Biological Chemistry.
[4] P. Gibson,et al. Activation of protein kinase C augments butyrate-induced differentiation and turnover in human colonic epithelial cells in vitro. , 1999, Carcinogenesis.
[5] N. Petrelli,et al. Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes. , 1998, Gastroenterology.
[6] W. Karnes,et al. PKC isoforms in intestinal mucosa and adenomas of APCMIN mice , 1998 .
[7] C. Stein,et al. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] P. Codogno,et al. Expression and posttranslational fate of cathepsin D in HT-29 tumor cells depend on their enterocytic differentiation state. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[9] Y. Pommier,et al. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53. , 1997, Experimental cell research.
[10] J. Lord,et al. Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. , 1997, Molecular pathology : MP.
[11] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[12] R. Brown,et al. Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. , 1996, Molecular pharmacology.
[13] C. Tacchetti,et al. Apoptosis of L929 cells by etoposide: a quantitative and kinetic approach. , 1996, Experimental cell research.
[14] B. Rigas,et al. Staurosporine inhibits the proliferation, alters the cell cycle distribution and induces apoptosis in HT-29 human colon adenocarcinoma cells. , 1996, Cancer letters.
[15] B. Marian,et al. Protein kinase C tissue localization in human colonic tumors suggests a role for adenoma growth control. , 1996, Gastroenterology.
[16] P. Bergman,et al. Partial Reversal of Multidrug Resistance in Human Breast Cancer Cells by an N-Myristoylated Protein Kinase C- Pseudosubstrate Peptide (*) , 1996, The Journal of Biological Chemistry.
[17] S. Targan,et al. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. , 1995, Journal of immunology.
[18] L. Dekker,et al. The protein kinase C and protein kinase C related gene families. , 1995, Current opinion in structural biology.
[19] I. Weinstein,et al. Expression of multiple isoforms of protein kinase C in normal human colon mucosa and colon tumors and decreased levels of protein kinase C β and η mRNAs in the tumors , 1994, Molecular carcinogenesis.
[20] K. Kohn,et al. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. , 1994, Cancer research.
[21] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[22] R. Slebos,et al. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. , 1993, Cancer research.
[23] J. Hickman,et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. , 1993, The EMBO journal.
[24] S. Arbuck,et al. Taxol: the first of the taxanes, an important new class of antitumor agents. , 1992, Seminars in oncology.
[25] N. Shen,et al. Apoptosis and DNA fragmentation precede TNF‐induced cytolysis in U937 cells , 1992, Journal of cellular biochemistry.
[26] I. Weinstein,et al. The modulation of growth by HMBA in PKC overproducing HT29 colon cancer cells. , 1991, Biochemical and biophysical research communications.
[27] J. Utsunomiya,et al. Protein kinase C activity as marker for colorectal cancer , 1991, International journal of cancer.
[28] P. Walker,et al. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. , 1991, Cancer research.
[29] I. Weinstein,et al. Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression , 1990, Molecular and cellular biology.
[30] M. Mattern,et al. Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation. , 1990, Cancer research.
[31] J. Tavernier,et al. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. , 1986, Journal of immunology.
[32] L. Liu,et al. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. , 1984, Cancer research.
[33] F. Schildberg,et al. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. , 1991, Cancer research.
[34] F. Balkwill,et al. DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon‐γ , 1987, European journal of immunology.